Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein

[1] Wang W(2020)Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China J Med Virol 92 441-447

[2] Tang J(2020)COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives Nat Rev Cardiol 17 543-558

[3] Wei F(2020)Obesity and diabetes as comorbidities for COVID-19: underlying mechanisms and the role of viral-bacterial interactions Elife 15 1991-3458

[4] Nishiga M(2020)The impact of pre-existing comorbidities and therapeutic interventions on COVID-19 Front Immunol 11 3449-9

[5] Wang DW(2021)Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors J Biomol Struct Dyn 39 E1-33243

[6] Han Y(2000)A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9 Circ Res 87 33238-e1818

[7] Lewis DB(2000)A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase J Biol Chem 275 e01815-360

[8] Wu JC(2019)TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection J Virol 93 350-D159

[9] Kruglikov IL(2021)An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non-structural protein-15 of SARS-CoV-2 Food Chem 1 5007-450

[10] Shah M(2020)Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions AIMS Microbiol 6 D154-461

[1] Wang W(2020)Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China J Med Virol 92 441-447

[2] Tang J(2020)COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives Nat Rev Cardiol 17 543-558

[3] Wei F(2020)Obesity and diabetes as comorbidities for COVID-19: underlying mechanisms and the role of viral-bacterial interactions Elife 15 1991-3458

[4] Nishiga M(2020)The impact of pre-existing comorbidities and therapeutic interventions on COVID-19 Front Immunol 11 3449-9

[5] Wang DW(2021)Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors J Biomol Struct Dyn 39 E1-33243

[6] Han Y(2000)A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9 Circ Res 87 33238-e1818

[7] Lewis DB(2000)A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase J Biol Chem 275 e01815-360

[8] Wu JC(2019)TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection J Virol 93 350-D159

[9] Kruglikov IL(2021)An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non-structural protein-15 of SARS-CoV-2 Food Chem 1 5007-450

[10] Shah M(2020)Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions AIMS Microbiol 6 D154-461